EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Regulation of Safracin Biosynthesis and Transport in Pseudomonas poae PMA22

J Gerardo Hernández Delgado, Miguel G Acedos iD, Fernando de la Calle iD, Pilar Rodríguez, José Luis García, Beatriz Galán iD

Marine Drugs · 2024

DOI: 10.3390/md22090418 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Marine Drugs, 2024. Verfasst von J Gerardo Hernández Delgado und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biothecnology, Centro de Investigaciones Biológicas Margarita Salas, Agencia Estatal Consejo Superior de Investigaciones Científicas (C…. Hauptthemen laut MEDLINE: Pseudomonas, Multigene Family, Bacterial Proteins, Gene Expression Regulation, Bacterial. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Economía y Competitividad, Ministry of Economy and Competitiveness of Spain.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pseudomonas poae PMA22 produces safracins, a family of compounds with potent broad-spectrum anti-bacterial and anti-tumor activities. The safracins’ biosynthetic gene cluster (BGC sac) consists of 11 ORFs organized in two divergent operons (sacABCDEFGHK and sacIJ) that are controlled by Pa and Pi promoters. Contiguous to the BGC sac, we have located a gene that encodes a putative global regulator of the LysR family annotated as MexT that was originally described as a transcriptional activator of the MexEF-OprN multidrug efflux pump in Pseudomonas. Through both in vitro and in vivo experiments, we have demonstrated the involvement of the dual regulatory system MexT-MexS on the BGC sac expression acting as an activator and a repressor, respectively. The MexEF-OprN transport system of PMA22, also controlled by MexT, was shown to play a fundamental role in the metabolism of safracin. The overexpression of mexEF-oprN in PMA22 resulted in fourfold higher production levels of safracin. These results illustrate how a pleiotropic regulatory system can be critical to optimizing the production of tailored secondary metabolites, not only through direct interaction with the BGC promoters, but also by controlling their transport.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PseudomonasMultigene FamilyBacterial ProteinsGene Expression Regulation, BacterialPromoter Regions, GeneticAnti-Bacterial AgentsBiological TransportOperon

Stichwörter der Autor:innen

biosynthetic cluster genes (BGCs)nonribosomal peptidessafracintranscriptional regulationtransporter genes

Substanzen

Bacterial ProteinsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Biothecnology, Centro de Investigaciones Biológicas Margarita Salas, Agencia Estatal Consejo Superior de Investigaciones Científicas (CSIC), 28040 Madrid, Spain.
  • Research and Development Department, PharmaMar S.A., 28770 Madrid, Spain.

ORCID-Profile: Miguel G Acedos, Fernando de la Calle, Beatriz Galán

Förderung

  • Ministerio de Economía y Competitividad
  • Ministry of Economy and Competitiveness of Spain

Zitieren

APA

Hernández Delgado, J. G., Acedos, M. G., de la Calle, F., Rodríguez, P., García, J. L., & Galán, B. (2024). Regulation of Safracin Biosynthesis and Transport in Pseudomonas poae PMA22. Marine Drugs. https://doi.org/10.3390/md22090418

Vancouver

Hernández Delgado JG, Acedos MG, de la Calle F, Rodríguez P, García JL, Galán B. Regulation of Safracin Biosynthesis and Transport in Pseudomonas poae PMA22. Marine Drugs. 2024. doi:10.3390/md22090418

BibTeX
@article{HernndezDelgado2024,
  author = {Hernández Delgado, J Gerardo and Acedos, Miguel G and de la Calle, Fernando and Rodríguez, Pilar and García, José Luis and Galán, Beatriz},
  title = {Regulation of Safracin Biosynthesis and Transport in Pseudomonas poae PMA22},
  journal = {Marine Drugs},
  year = {2024},
  doi = {10.3390/md22090418}
}
Kostenlos starten →